ENT and Head & Neck Research Center and Department, The Five Senses Institute, Iran University of Medical Sciences, Tehran, Iran.
Frequency Acupuncture Diploma, Frequency Acupuncture and Laser Acupuncture Clinic, Tehran, Iran.
J Acupunct Meridian Stud. 2024 Apr 30;17(2):69-75. doi: 10.51507/j.jams.2024.17.2.69.
Olfactory dysfunction is a common COVID-19 symptom, posing treatment challenges.
We aimed to investigate the efficacy of frequency-controlled ear acupuncture in treating COVID-19-related olfactory dysfunction.
A randomized, participant-blind clinical trial occurred at the Rasoul Akram Hospital (IRCT20210311050671N1). Forty patients were recruited, and 20 patients were randomly assigned to either the experimental or control group. The primary outcome was the improvement in patients' quality of smell. The olfactory dysfunction was confirmed using the Smell Identification Test. The intervention group received two sessions of acupuncture treatment according to auricular frequency treatment, with a one-week interval, while the control group received an equal number of switched-off laser sessions. Both groups were instructed to use nasal betamethasone drops. The patients were asked to rank their ability to smell before and after each intervention on a 10-point visual analog scale. Secondary outcomes were related side effects.
Covariance analysis revealed a significant difference in adjusted scores between the groups (F [37, 1] = 37.463; = 0.000, Eta = 0.503). The smell quality improved from 2.80 ± 1.76 to 5.22 ± 3.40 after treatment in the intervention group ( = 0.007), while the control group showed no significant change ( = 0.184). Three patients reported short and transient side effects, such as nausea, headache, and dizziness, in the first hours after the intervention.
Frequency-controlled ear acupuncture is an effective option for treating COVID-19-related olfactory dysfunction. The study highlights the potential of alternative therapies in the treatment of this condition, and further research is warranted to investigate its long-term effects.
嗅觉功能障碍是 COVID-19 的常见症状,给治疗带来了挑战。
本研究旨在探究频率控制耳针治疗 COVID-19 相关嗅觉功能障碍的疗效。
这是一项在拉苏尔阿克拉姆医院(IRCT20210311050671N1)进行的随机、参与者盲法临床试验。共招募了 40 名患者,将 20 名患者随机分为实验组和对照组。主要结局指标是患者嗅觉质量的改善。嗅觉功能障碍通过嗅觉识别测试来确认。实验组根据耳穴频率治疗接受两次针灸治疗,间隔一周,而对照组接受相同次数的关闭激光治疗。两组均被指示使用鼻用倍他米松滴剂。患者在每次干预前后使用 10 分制视觉模拟量表对自己的嗅觉能力进行评分。次要结局指标为相关不良反应。
协方差分析显示,两组调整后的评分存在显著差异(F [37, 1] = 37.463; = 0.000,Eta = 0.503)。实验组治疗后嗅觉质量从 2.80 ± 1.76 提高到 5.22 ± 3.40( = 0.007),而对照组无明显变化( = 0.184)。有 3 名患者在干预后最初几小时报告了短暂的不良反应,如恶心、头痛和头晕。
频率控制耳针是治疗 COVID-19 相关嗅觉功能障碍的有效方法。该研究强调了替代疗法在治疗这种疾病中的潜力,需要进一步研究来探讨其长期效果。